[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

United States Insulin API Market Report 2017

October 2017 | 104 pages | ID: U6E55580C78WEN
QYResearch

US$ 3,800.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
In this report, the United States Insulin API market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report splits the United States market into seven regions:
  • The West
  • Southwest
  • The Middle Atlantic
  • New England
  • The South
  • The Midwest
  • with sales (volume), revenue (value), market share and growth rate of Insulin API in these regions, from 2012 to 2022 (forecast).
United States Insulin API market competition by top manufacturers/players, with Insulin API sales volume, price, revenue (Million USD) and market share for each manufacturer/player; the top players including
  • Novo Nordisk
  • Eli Lilly
  • Sanofi
  • Tong Hua Dong Bao Group
  • Ganlee
  • United Laboratories
On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into
  • Regular Human Insulin
  • Insulin Analogue
On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate of Insulin API for each application, including
  • Short Acting Insulin
  • Intermediate Acting Insulin
  • Long Acting Insulin
  • Pre-Mix Insulin
If you have any special requirements, please let us know and we will offer you the report as you want.
United States Insulin API Market Report 2017

1 INSULIN API OVERVIEW

1.1 Product Overview and Scope of Insulin API
1.2 Classification of Insulin API by Product Category
  1.2.1 United States Insulin API Market Size (Sales Volume) Comparison by Type (2012-2022)
  1.2.2 United States Insulin API Market Size (Sales Volume) Market Share by Type (Product Category) in 2016
  1.2.3 Regular Human Insulin
  1.2.4 Insulin Analogue
1.3 United States Insulin API Market by Application/End Users
  1.3.1 United States Insulin API Market Size (Consumption) and Market Share Comparison by Application (2012-2022)
  1.3.2 Short Acting Insulin
  1.3.3 Intermediate Acting Insulin
  1.3.4 Long Acting Insulin
  1.3.5 Pre-Mix Insulin
1.4 United States Insulin API Market by Region
  1.4.1 United States Insulin API Market Size (Value) Comparison by Region (2012-2022)
  1.4.2 The West Insulin API Status and Prospect (2012-2022)
  1.4.3 Southwest Insulin API Status and Prospect (2012-2022)
  1.4.4 The Middle Atlantic Insulin API Status and Prospect (2012-2022)
  1.4.5 New England Insulin API Status and Prospect (2012-2022)
  1.4.6 The South Insulin API Status and Prospect (2012-2022)
  1.4.7 The Midwest Insulin API Status and Prospect (2012-2022)
1.5 United States Market Size (Value and Volume) of Insulin API (2012-2022)
  1.5.1 United States Insulin API Sales and Growth Rate (2012-2022)
  1.5.2 United States Insulin API Revenue and Growth Rate (2012-2022)

2 UNITED STATES INSULIN API MARKET COMPETITION BY PLAYERS/SUPPLIERS

2.1 United States Insulin API Sales and Market Share of Key Players/Suppliers (2012-2017)
2.2 United States Insulin API Revenue and Share by Players/Suppliers (2012-2017)
2.3 United States Insulin API Average Price by Players/Suppliers (2012-2017)
2.4 United States Insulin API Market Competitive Situation and Trends
  2.4.1 United States Insulin API Market Concentration Rate
  2.4.2 United States Insulin API Market Share of Top 3 and Top 5 Players/Suppliers
  2.4.3 Mergers & Acquisitions, Expansion in United States Market
2.5 United States Players/Suppliers Insulin API Manufacturing Base Distribution, Sales Area, Product Type

3 UNITED STATES INSULIN API SALES (VOLUME) AND REVENUE (VALUE) BY REGION (2012-2017)

3.1 United States Insulin API Sales and Market Share by Region (2012-2017)
3.2 United States Insulin API Revenue and Market Share by Region (2012-2017)
3.3 United States Insulin API Price by Region (2012-2017)

4 UNITED STATES INSULIN API SALES (VOLUME) AND REVENUE (VALUE) BY TYPE (PRODUCT CATEGORY) (2012-2017)

4.1 United States Insulin API Sales and Market Share by Type (Product Category) (2012-2017)
4.2 United States Insulin API Revenue and Market Share by Type (2012-2017)
4.3 United States Insulin API Price by Type (2012-2017)
4.4 United States Insulin API Sales Growth Rate by Type (2012-2017)

5 UNITED STATES INSULIN API SALES (VOLUME) BY APPLICATION (2012-2017)

5.1 United States Insulin API Sales and Market Share by Application (2012-2017)
5.2 United States Insulin API Sales Growth Rate by Application (2012-2017)
5.3 Market Drivers and Opportunities

6 UNITED STATES INSULIN API PLAYERS/SUPPLIERS PROFILES AND SALES DATA

6.1 Novo Nordisk
  6.1.1 Company Basic Information, Manufacturing Base and Competitors
  6.1.2 Insulin API Product Category, Application and Specification
    6.1.2.1 Product A
    6.1.2.2 Product B
  6.1.3 Novo Nordisk Insulin API Sales, Revenue, Price and Gross Margin (2012-2017)
  6.1.4 Main Business/Business Overview
6.2 Eli Lilly
  6.2.2 Insulin API Product Category, Application and Specification
    6.2.2.1 Product A
    6.2.2.2 Product B
  6.2.3 Eli Lilly Insulin API Sales, Revenue, Price and Gross Margin (2012-2017)
  6.2.4 Main Business/Business Overview
6.3 Sanofi
  6.3.2 Insulin API Product Category, Application and Specification
    6.3.2.1 Product A
    6.3.2.2 Product B
  6.3.3 Sanofi Insulin API Sales, Revenue, Price and Gross Margin (2012-2017)
  6.3.4 Main Business/Business Overview
6.4 Tong Hua Dong Bao Group
  6.4.2 Insulin API Product Category, Application and Specification
    6.4.2.1 Product A
    6.4.2.2 Product B
  6.4.3 Tong Hua Dong Bao Group Insulin API Sales, Revenue, Price and Gross Margin (2012-2017)
  6.4.4 Main Business/Business Overview
6.5 Ganlee
  6.5.2 Insulin API Product Category, Application and Specification
    6.5.2.1 Product A
    6.5.2.2 Product B
  6.5.3 Ganlee Insulin API Sales, Revenue, Price and Gross Margin (2012-2017)
  6.5.4 Main Business/Business Overview
6.6 United Laboratories
  6.6.2 Insulin API Product Category, Application and Specification
    6.6.2.1 Product A
    6.6.2.2 Product B
  6.6.3 United Laboratories Insulin API Sales, Revenue, Price and Gross Margin (2012-2017)
  6.6.4 Main Business/Business Overview

7 INSULIN API MANUFACTURING COST ANALYSIS

7.1 Insulin API Key Raw Materials Analysis
  7.1.1 Key Raw Materials
  7.1.2 Price Trend of Key Raw Materials
  7.1.3 Key Suppliers of Raw Materials
  7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
  7.2.1 Raw Materials
  7.2.2 Labor Cost
  7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of Insulin API

8 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

8.1 Insulin API Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of Insulin API Major Manufacturers in 2016
8.4 Downstream Buyers

9 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

9.1 Marketing Channel
  9.1.1 Direct Marketing
  9.1.2 Indirect Marketing
  9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
  9.2.1 Pricing Strategy
  9.2.2 Brand Strategy
  9.2.3 Target Client
9.3 Distributors/Traders List

10 MARKET EFFECT FACTORS ANALYSIS

10.1 Technology Progress/Risk
  10.1.1 Substitutes Threat
  10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change

11 UNITED STATES INSULIN API MARKET SIZE (VALUE AND VOLUME) FORECAST (2017-2022)

11.1 United States Insulin API Sales Volume, Revenue Forecast (2017-2022)
11.2 United States Insulin API Sales Volume Forecast by Type (2017-2022)
11.3 United States Insulin API Sales Volume Forecast by Application (2017-2022)
11.4 United States Insulin API Sales Volume Forecast by Region (2017-2022)

12 RESEARCH FINDINGS AND CONCLUSION

13 APPENDIX

13.1 Methodology/Research Approach
  13.1.1 Research Programs/Design
  13.1.2 Market Size Estimation
  13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
  13.2.1 Secondary Sources
  13.2.2 Primary Sources
13.3 Disclaimer


The report requires updating with new data and is sent in 2-3 business days after order is placed.


LIST OF TABLES AND FIGURES

Figure Product Picture of Insulin API
Figure United States Insulin API Market Size (Kg) by Type (2012-2022)
Figure United States Insulin API Sales Volume Market Share by Type (Product Category) in 2016
Figure Regular Human Insulin Product Picture
Figure Insulin Analogue Product Picture
Figure United States Insulin API Market Size (Kg) by Application (2012-2022)
Figure United States Sales Market Share of Insulin API by Application in 2016
Figure Short Acting Insulin Examples
Table Key Downstream Customer in Short Acting Insulin
Figure Intermediate Acting Insulin Examples
Table Key Downstream Customer in Intermediate Acting Insulin
Figure Long Acting Insulin Examples
Table Key Downstream Customer in Long Acting Insulin
Figure Pre-Mix Insulin Examples
Table Key Downstream Customer in Pre-Mix Insulin
Figure United States Insulin API Market Size (Million USD) by Region (2012-2022)
Figure The West Insulin API Revenue (Million USD) and Growth Rate (2012-2022)
Figure Southwest Insulin API Revenue (Million USD) and Growth Rate (2012-2022)
Figure The Middle Atlantic Insulin API Revenue (Million USD) and Growth Rate (2012-2022)
Figure New England Insulin API Revenue (Million USD) and Growth Rate (2012-2022)
Figure The South of US Insulin API Revenue (Million USD) and Growth Rate (2012-2022)
Figure The Midwest Insulin API Revenue (Million USD) and Growth Rate (2012-2022)
Figure United States Insulin API Sales (Kg) and Growth Rate (2012-2022)
Figure United States Insulin API Revenue (Million USD) and Growth Rate (2012-2022)
Figure United States Insulin API Market Major Players Product Sales Volume (Kg) (2012-2017)
Table United States Insulin API Sales (Kg) of Key Players/Suppliers (2012-2017)
Table United States Insulin API Sales Share by Players/Suppliers (2012-2017)
Figure 2016 United States Insulin API Sales Share by Players/Suppliers
Figure 2017 United States Insulin API Sales Share by Players/Suppliers
Figure United States Insulin API Market Major Players Product Revenue (Million USD) (2012-2017)
Table United States Insulin API Revenue (Million USD) by Players/Suppliers (2012-2017)
Table United States Insulin API Revenue Share by Players/Suppliers (2012-2017)
Figure 2016 United States Insulin API Revenue Share by Players/Suppliers
Figure 2017 United States Insulin API Revenue Share by Players/Suppliers
Table United States Market Insulin API Average Price (USD/Kg) of Key Players/Suppliers (2012-2017)
Figure United States Market Insulin API Average Price (USD/Kg) of Key Players/Suppliers in 2016
Figure United States Insulin API Market Share of Top 3 Players/Suppliers
Figure United States Insulin API Market Share of Top 5 Players/Suppliers
Table United States Players/Suppliers Insulin API Manufacturing Base Distribution and Sales Area
Table United States Players/Suppliers Insulin API Product Category
Table United States Insulin API Sales (Kg) by Region (2012-2017)
Table United States Insulin API Sales Share by Region (2012-2017)
Figure United States Insulin API Sales Share by Region (2012-2017)
Figure United States Insulin API Sales Market Share by Region in 2016
Table United States Insulin API Revenue (Million USD) and Market Share by Region (2012-2017)
Table United States Insulin API Revenue Share by Region (2012-2017)
Figure United States Insulin API Revenue Market Share by Region (2012-2017)
Figure United States Insulin API Revenue Market Share by Region in 2016
Table United States Insulin API Price (USD/Kg) by Region (2012-2017)
Table United States Insulin API Sales (Kg) by Type (2012-2017)
Table United States Insulin API Sales Share by Type (2012-2017)
Figure United States Insulin API Sales Share by Type (2012-2017)
Figure United States Insulin API Sales Market Share by Type in 2016
Table United States Insulin API Revenue (Million USD) and Market Share by Type (2012-2017)
Table United States Insulin API Revenue Share by Type (2012-2017)
Figure Revenue Market Share of Insulin API by Type (2012-2017)
Figure Revenue Market Share of Insulin API by Type in 2016
Table United States Insulin API Price (USD/Kg) by Types (2012-2017)
Figure United States Insulin API Sales Growth Rate by Type (2012-2017)
Table United States Insulin API Sales (Kg) by Application (2012-2017)
Table United States Insulin API Sales Market Share by Application (2012-2017)
Figure United States Insulin API Sales Market Share by Application (2012-2017)
Figure United States Insulin API Sales Market Share by Application in 2016
Table United States Insulin API Sales Growth Rate by Application (2012-2017)
Figure United States Insulin API Sales Growth Rate by Application (2012-2017)
Table Novo Nordisk Basic Information List
Table Novo Nordisk Insulin API Sales (Kg), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2012-2017)
Figure Novo Nordisk Insulin API Sales Growth Rate (2012-2017)
Figure Novo Nordisk Insulin API Sales Market Share in United States (2012-2017)
Figure Novo Nordisk Insulin API Revenue Market Share in United States (2012-2017)
Table Eli Lilly Basic Information List
Table Eli Lilly Insulin API Sales (Kg), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2012-2017)
Figure Eli Lilly Insulin API Sales Growth Rate (2012-2017)
Figure Eli Lilly Insulin API Sales Market Share in United States (2012-2017)
Figure Eli Lilly Insulin API Revenue Market Share in United States (2012-2017)
Table Sanofi Basic Information List
Table Sanofi Insulin API Sales (Kg), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2012-2017)
Figure Sanofi Insulin API Sales Growth Rate (2012-2017)
Figure Sanofi Insulin API Sales Market Share in United States (2012-2017)
Figure Sanofi Insulin API Revenue Market Share in United States (2012-2017)
Table Tong Hua Dong Bao Group Basic Information List
Table Tong Hua Dong Bao Group Insulin API Sales (Kg), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2012-2017)
Figure Tong Hua Dong Bao Group Insulin API Sales Growth Rate (2012-2017)
Figure Tong Hua Dong Bao Group Insulin API Sales Market Share in United States (2012-2017)
Figure Tong Hua Dong Bao Group Insulin API Revenue Market Share in United States (2012-2017)
Table Ganlee Basic Information List
Table Ganlee Insulin API Sales (Kg), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2012-2017)
Figure Ganlee Insulin API Sales Growth Rate (2012-2017)
Figure Ganlee Insulin API Sales Market Share in United States (2012-2017)
Figure Ganlee Insulin API Revenue Market Share in United States (2012-2017)
Table United Laboratories Basic Information List
Table United Laboratories Insulin API Sales (Kg), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2012-2017)
Figure United Laboratories Insulin API Sales Growth Rate (2012-2017)
Figure United Laboratories Insulin API Sales Market Share in United States (2012-2017)
Figure United Laboratories Insulin API Revenue Market Share in United States (2012-2017)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Insulin API
Figure Manufacturing Process Analysis of Insulin API
Figure Insulin API Industrial Chain Analysis
Table Raw Materials Sources of Insulin API Major Players/Suppliers in 2016
Table Major Buyers of Insulin API
Table Distributors/Traders List
Figure United States Insulin API Sales Volume (Kg) and Growth Rate Forecast (2017-2022)
Figure United States Insulin API Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure United States Insulin API Price (USD/Kg) Trend Forecast (2017-2022)
Table United States Insulin API Sales Volume (Kg) Forecast by Type (2017-2022)
Figure United States Insulin API Sales Volume (Kg) Forecast by Type (2017-2022)
Figure United States Insulin API Sales Volume (Kg) Forecast by Type in 2022
Table United States Insulin API Sales Volume (Kg) Forecast by Application (2017-2022)
Figure United States Insulin API Sales Volume (Kg) Forecast by Application (2017-2022)
Figure United States Insulin API Sales Volume (Kg) Forecast by Application in 2022
Table United States Insulin API Sales Volume (Kg) Forecast by Region (2017-2022)
Table United States Insulin API Sales Volume Share Forecast by Region (2017-2022)
Figure United States Insulin API Sales Volume Share Forecast by Region (2017-2022)
Figure United States Insulin API Sales Volume Share Forecast by Region in 2022
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources


More Publications